AbbVie partners with Iambic in AI

{
  "signal_id": "dceff260-9819-1c11-b39b-aea22fbea787",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-09-21T12:07:24+00:00",
  "company": {
    "name": "AbbVie",
    "domain": "abbvie.com"
  },
  "data": {
    "url": "https://ch.marketscreener.com/boerse-nachrichten/abbvie-kooperiert-mit-iambic-im-bereich-ki-ce785adbdc89f321",
    "title": "AbbVie partners with Iambic in AI - ch.marketscreener.com",
    "excerpt": "The pharmaceutical company and the technology and life sciences company Iambic today announced the conclusion of a multi-year partnership aimed at accelerating the discovery and development of innovative drug molecules. The collaboration covers immunology, neurobiology, and oncology. Jean-Yves Courtial Published on 09/21/2026 at 2:07 PM Contact us if you would like a correction",
    "summary": "AbbVie has entered into a multi-year partnership with Iambic to accelerate the discovery and development of innovative drug molecules in immunology, neurobiology, and oncology.",
    "planning": false,
    "image_url": "https://cdn.zonebourse.com/static/resize/0/0//images//reuters/2025-06-10T180330Z_1_LYNXMPEL590XD_RTROPTP_4_ABBVIE-USA.JPG",
    "confidence": 0.9,
    "published_at": "2026-09-21T12:07:24Z",
    "effective_date": "2026-09-21",
    "article_sentence": "The pharmaceutical company and the technology and life sciences company Iambic today announced the conclusion of a multi-year partnership aimed at accelerating the discovery and development of innovative drug molecules.",
    "related_company_name": "Iambic",
    "related_company_domain": "iambic.ai"
  }
}

curl https://signals.autobound.ai/v1/signals/dceff260-9819-1c11-b39b-aea22fbea787 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"abbvie.com","limit":20}'